• KOL
    • Cellular Uptake
    • Mengqin Zhu
    • Mengqin Zhu: Influence Statistics

      Mengqin Zhu

      Mengqin Zhu

      School of Pharmaceutical Sciences, Jiangnan University, Wuxi 214122, Jiangsu, China. | Department of Pharmaceutics, School of Pharmaceutical Sciences, Jiangnan University, ...

      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

      Mengqin Zhu:Expert Impact

      Concepts for whichMengqin Zhuhas direct influence:Cellular uptake,Doxorubicin resistance,Hod micelles,Dox hod,Hyaluronic acid,Dox hod micelles,Micelles dox,Mdr dnvm.

      Mengqin Zhu:KOL impact

      Concepts related to the work of other authors for whichfor which Mengqin Zhu has influence:Polymeric micelles,Hyaluronic acid,Cellular uptake,Chemotherapeutic agents,Specific biomolecules,Natural biopolymers,Dox release.

      KOL Resume for Mengqin Zhu

      Year
      2021

      School of Pharmaceutical Sciences, Jiangnan University, Wuxi 214122, Jiangsu, China.

      2017

      Department of Pharmaceutics, School of Pharmaceutical Sciences, Jiangnan University, Wuxi 214122, PR China

      2016

      School of Pharmaceutical Sciences

      Jiangnan University

      Wuxi 214122

      PR China

      Sign-in to see all concepts, it's free!
      Sample of concepts for which Mengqin Zhu is among the top experts in the world.
      Concept World rank
      acid2octadecyloxy13 dioxan5 #3
      hyaluronic acid2octadecyloxy13 #3
      acid2octadecyloxy13 #3
      amine hod #4
      hod micelles #4
      dioxan5 amine #4
      dox hod micelles #4
      loaded hod micelles #5
      acidinsensitive doxves #5
      ves loaded #5
      dnvm synergistically #5
      gain dnvm #5
      mdr reversal dnvm #5
      ves prodrug #5
      developed dnvm #5
      caveolaemediated routes #5
      dnvm efficacy #5
      double gain dnvm #5
      dnvm mdr #5
      doxloaded hod micelles #5
      ves sensitive #5
      dox hod dox #5
      dox vitamin succinate #5
      doxnnves prodrug #5
      reversal dnvm #5
      loaded hod #5
      mdr dnvm #5
      phinduced degradable #5
      dnvm reversal #5
      dox hod #5
      2octadecyloxy13dioxan5amine #5
      dnvm inhibited #5
      potential tumor mdr #5
      dnvm dox #5
      dox dox hod #5
      sensitive hod #5
      presented dox #6
      function prodrug #7
      nonsensitive micelles #8
      hod studies #9
      hyaluronic acid micelles #9
      dox ves #10
      endocytosis inhibition studies #10
      dox vitamin #11
      chemotherapeutics potential #12
      dnvm #13
      hoa micelles #13
      drugconjugate #15
      mice hod #16
      micelles endocytosis #20
      Sign-in to see all concepts, it's free!

      Prominent publications by Mengqin Zhu

      KOL-Index: 5875

      2-(Octadecyloxy)-1,3-dioxan-5-amine (OD) with an acid degradable ortho ester group was synthesized, and conjugated to hyaluronic acid (HA) backbone to prepare pH-responsive and tumor-targeted hyaluronic acid-2-(octadecyloxy)-1,3-dioxan-5-amine (HOD) conjugates. 1H NMR was used to confirm the structures of the OD and HOD. The studies of pH-responsive behavior showed that HOD micelles were stable under physiological conditions while they were degraded in the tumor acidic microenvironment. ...

      Known for Tumor Drug | Hod Micelles | Mcf7 Cells | Physiological Conditions | Vitro Cytotoxicity
      KOL-Index: 2853

      DOX/HM23, based on appropriate DS and proper particle size, presented enhanced anticancer activity and efficient internalization to achieve the highest intracellular drug concentration.

      Plenty of hyaluronic acid (HA) drug delivery systems have been developed to target cancer cells. Carboxyl of HA is the active group for targeting CD44 receptor, which is overexpressed in several different types of cancer cells. To verify whether the number of carboxyl is the main ...

      Known for Drug Delivery | Hyaluronic Acid | Cancer Cells | Micelles Dox | Cd44 Receptor
      KOL-Index: 1724

      To improve the targeting efficacy of hyaluronic acid (HA)-based micelles, pH-sensitive mixed micelles based on HA-g-poly(L-histidine) (PHis) and d-α-tocopheryl polyethylene glycol 2000 copolymers were prepared and decorated with human epidermal growth factor receptor 2 (Her2) peptide, a tumor cell-specific peptide ligand, on their surface. The doxorubicin-loaded micelles (HA-PHis/peptide-d-α-tocopheryl polyethylene glycol 2000 mixed micelles [PHTM]) were characterized to have a unimodal ...

      Known for Cellular Uptake | Specific Peptide | Hyaluronic Acid | Drug Carriers | Receptor Erbb2
      KOL-Index: 563

      Multidrug resistance (MDR) is the main challenge faced by cancer chemotherapy. Drug-conjugate offers a promising strategy for breast cancer therapy. In this regard, we developed a DNVM multifunctional drug delivery system by crosslinking doxorubicin (DOX) and vitamin E succinate (VES) with a pH-sensitive hydrazone bond and then encapsulated the DOX-NN-VES prodrug into pH-sensitive hyaluronic acid-2-(octadecyloxy)-1,3-dioxan-5-amine (HOD) micelles. DOX resistant MCF-7/ADR cell were ...

      Known for Hyaluronic Acid | Cancer Therapy | Stimuli Responsive

      Key People For Cellular Uptake

      Top KOLs in the world
      #1
      Robert S Langer
      drug delivery tissue engineering controlled release
      #2
      Warren C W Chan
      quantum dots gold nanoparticles endothelial cells
      #3
      Vladimir P Torchilin
      drug delivery cancer cells polymeric micelles
      #4
      Omid Cameron Farokhzad
      drug delivery cancer therapy protein corona
      #5
      Kenneth A Dawson
      protein corona silica nanoparticles lattice model
      #6
      B Devika Chithrani
      gold nanoparticles cellular uptake radiation therapy

      School of Pharmaceutical Sciences, Jiangnan University, Wuxi 214122, Jiangsu, China. | Department of Pharmaceutics, School of Pharmaceutical Sciences, Jiangnan University, Wuxi 214122, PR China | School of Pharmaceutical Sciences | Jiangnan Universit

    Download on the App StoreGet it on Google Play

    Copyright © 2023 KOL - Key Opinion Leaders, LLC.

    KOL does not provide medical advice, diagnosis or treatment.